Epidemiology of invasive neonatal Cronobacter (Enterobacter sakazakii) infections

被引:158
作者
Friedemann, M. [1 ]
机构
[1] BfR Fed Inst Risk Assessment, Berlin, Germany
关键词
POWDERED INFANT FORMULA; INTENSIVE-CARE-UNIT; MILK; OUTBREAK; MENINGITIS; BACTEREMIA; SEPSIS;
D O I
10.1007/s10096-009-0779-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
About 120-150 neonatal Cronobacter spp. (Enterobacter sakazakii) infections have been described. An analysis of current case numbers, epidemiological measures and risk factors is warranted. Data of microbiologically confirmed cases, published between 2000 and 2008, have been analysed statistically. More than 100 neonatal Cronobacter infections have been reported in this period. The overall lethality of the 67 invasive infections was 26.9%. The lethality of Cronobacter meningitis, bacteraemia and necrotising enterocolitis (NEC) was calculated to be 41.9% (P < 0.0001), < 10% and 19.0% (P < 0.05), respectively. Logistic regression models (P < 0.0001) revealed a higher gestational age at birth and parentage not from Europe as significant factors for a higher reporting probability of neonatal Cronobacter meningitis. Neonates with Cronobacter meningitis not originating from North America have a higher risk for lethal outcome than other neonatal Cronobacter infections (P < 0.0001). Continental differences of risk factors for Cronobacter meningitis and for the lethal outcome of neonatal meningitis should be elucidated. Neonatal Cronobacter infections are mainly associated with the contamination of infant formula and of the relevant cleaning and preparation equipment. Eleven neonatal Cronobacter infections, not caused by contaminated infant formula, have been retrieved. Other environmental sources of infection should be considered. Consistent and sufficiently informative data of invasive neonatal Cronobacter infections should be recorded in a centralized reporting system.
引用
收藏
页码:1297 / 1304
页数:8
相关论文
共 57 条
  • [1] Aguirre Conde A, 2007, An Pediatr (Barc), V66, P196
  • [2] In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections
    Amsler, Karen M.
    Davies, Todd A.
    Shang, Wenchi
    Jacobs, Michael R.
    Bush, Karen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) : 3418 - 3423
  • [3] OUTBREAK OF COLONIZATION OF NEONATES WITH ENTEROBACTER-SAKAZAKII
    ARSENI, A
    MALAMOULADAS, E
    KOUTSIA, C
    XANTHOU, M
    TRIKKA, E
    [J]. JOURNAL OF HOSPITAL INFECTION, 1987, 9 (02) : 143 - 150
  • [4] Enterobacter sakazakii infection in the newborn
    Bar-Oz, B
    Preminger, A
    Peleg, O
    Block, C
    Arad, I
    [J]. ACTA PAEDIATRICA, 2001, 90 (03) : 356 - 358
  • [5] Barreira E.R., 2003, Pediatria, V25, P65
  • [6] Invasive Enterobacter sakazakii disease in infants
    Bowen, Anna B.
    Braden, Christopher R.
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (08) : 1185 - 1189
  • [7] Enterobacter sakazakii brain abscess in the neonate:: the importance of neuroradiologic imaging
    Burdette, JH
    Santos, C
    [J]. PEDIATRIC RADIOLOGY, 2000, 30 (01) : 33 - 34
  • [8] Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France
    Caubilla-Barron, J.
    Hurrell, E.
    Townsend, S.
    Cheetham, P.
    Loc-Carrillo, C.
    Fayet, O.
    Prere, M. -F.
    Forsythe, S. J.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (12) : 3979 - 3985
  • [9] *CDR, 1993, CDR WKLY, V3, P1
  • [10] *CDR, 2004, BACT 2003 ENGL WAL N